Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Jan;31(1):100–101. doi: 10.1128/aac.31.1.100

In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.

J Segreti, H A Kessler, K S Kapell, G M Trenholme
PMCID: PMC174660  PMID: 2952061

Abstract

The in vitro activity of A-56268 (TE-031), a new macrolide antibiotic, against 11 strains of Chlamydia trachomatis was determined and compared with that of four other antibiotics. A-56268 was the most active drug tested. Doxycycline, trimethoprim-sulfamethoxazole, and erythromycin had good activity but were less active in vitro than A-56268.

Full text

PDF
100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowie W. R., Lee C. K., Alexander E. R. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis. J Infect Dis. 1978 Nov;138(5):655–659. doi: 10.1093/infdis/138.5.655. [DOI] [PubMed] [Google Scholar]
  2. Hammerschlag M. R. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro. Rev Infect Dis. 1982 Mar-Apr;4(2):500–505. doi: 10.1093/clinids/4.2.500. [DOI] [PubMed] [Google Scholar]
  3. Hammerschlag M. R., Vuletin J. C. Ultrastructural analysis of the effect of trimethoprim and sulphamethoxazole on the development of Chlamydia trachomatis in cell culture. J Antimicrob Chemother. 1985 Feb;15(2):209–217. doi: 10.1093/jac/15.2.209. [DOI] [PubMed] [Google Scholar]
  4. Heessen F. W., Muytjens H. L. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis. Antimicrob Agents Chemother. 1984 Jan;25(1):123–124. doi: 10.1128/aac.25.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Johannisson G., Sernryd A., Lycke E. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo. Sex Transm Dis. 1979 Apr-Jun;6(2):50–57. doi: 10.1097/00007435-197904000-00002. [DOI] [PubMed] [Google Scholar]
  6. Kuo C. C., Wang S. P., Grayston J. T. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother. 1977 Jul;12(1):80–83. doi: 10.1128/aac.12.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rapoza P. A., Quinn T. C., Kiessling L. A., Green W. R., Taylor H. R. Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA. 1986 Jun 27;255(24):3369–3373. [PubMed] [Google Scholar]
  8. Ridgway G. L., Owen J. M., Oriel J. D. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. Br J Vener Dis. 1978 Apr;54(2):103–106. doi: 10.1136/sti.54.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Robson H. G., Shah P. P., Lalonde R. G., Hayes L., Senikas V. M. Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatis. Sex Transm Dis. 1983 Jul-Sep;10(3):130–134. doi: 10.1097/00007435-198307000-00006. [DOI] [PubMed] [Google Scholar]
  10. Scheibel J. H., Kristensen J. K., Hentzer B., Secher L., Ullman S., Verdich J., Weismann K. Treatment of chlamydial urethritis in men and Chlamydia trachomatis-positive female partners: comparison of erythromycin and tetracycline in treatment courses of one week. Sex Transm Dis. 1982 Jul-Sep;9(3):128–131. doi: 10.1097/00007435-198207000-00005. [DOI] [PubMed] [Google Scholar]
  11. Smith T. F., Washton H. E. In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin. Antimicrob Agents Chemother. 1978 Sep;14(3):493–494. doi: 10.1128/aac.14.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES